Description
Pharmacological action
Field of application – orthopedics, rheumatology, traumatology, surgery, sports medicine. Therapy for severe osteoarthritis.
Armaviscon Forte is a protector of synovial fluid of the joint. It is used against the background of degenerative changes in the surface of the synovial cartilage to improve joint mobility, reduce pain, reduce inflammatory reactions and restore homeostasis in the cartilage.
Properties and efficacy: The product has an analgesic, corrective effect on the metabolism of bone and cartilage.
Armaviscon Forte is a sterile, viscous solution of sodium salt of hyaluronic acid (sodium hyaluronate) with a high degree of purification, high molecular weight.
Hyaluronic acid – a necessary component of the extracellular matrix, is present in high concentrations in the composition of cartilage and synovial fluid. Hyaluronic acid provides the viscosity and elasticity of the synovial fluid, and it is also necessary for the formation of cartilage. With osteoarthritis, deficiency and qualitative changes in hyaluronic acid in the composition of synovial fluid and cartilage are noted.
Intra-articular administration of hyaluronic acid leads to an improvement in the functional state of the joint.
When using Armaviscon Forte with osteoarthritis of the knee, an improvement in the clinical course of osteoarthritis is observed up to six months from the time of use, an anti-inflammatory and analgesic effect is observed due to replenishment of the volume and restoration of the viscosity and elasticity of the synovial fluid, which fills the joint cavity and acts as an intraarticular lubricant.
It prevents the friction of articular surfaces, which eliminates pain and inflammation. It also protects against premature wear and destruction of hyaline cartilage, provides mobility, and has cushioning capabilities (dampens external shocks, protecting joint components from damage).
Hyaluronate sodium solution is distributed topically in the joint cavity, where it undergoes local transformations, providing a lubricating effect.
Removing or replacing the product is not applicable, as it is inextricably mixed with synovial fluid of the joint.
Indications
To increase joint mobility and eliminate pain caused by degenerative-dystrophic or post-traumatic joint changes
For rehabilitation after arthroscopy
For the treatment of patients with increased physical activity and regularly loading the affected joint.
Contraindications
Hypersensitivity to the components of
means the presence of infection or damage to the skin at the injection site
acute synovitis
children under 18 years of age (due to lack of clinical data).
Use during pregnancy and during breastfeeding: It is not recommended to use the product during pregnancy and during breastfeeding due to lack of clinical data. Prescribing during pregnancy and during breastfeeding at the discretion of the orthopedic surgeon.
Special instructions
Not a medicine.
is a medical device.
Means for intraarticular injection.
Precautions for use: Do not use Armaviscon Forte with damaged or opened packaging.
Sodium hyaluronate obtained by fermentation of bacteria Streptococcus equi and thoroughly cleaned. However, the doctor must consider the potential risk associated with the injection of any biological substance.
Extraarticular injection of Armaviscon Forte into a joint capsule or synovial tissue is not permitted. This can cause local side effects. It is unacceptable for the product to enter the blood vessels.
During the first 2 days after the procedure, it is recommended not to overload the joint, especially prolonged loading should be avoided.
Armaviscon Forte does not affect a person ² ¢s ability to drive vehicles, engage in other potentially dangerous activities that require increased concentration of attention and speed of psychomotor reactions.
Patients with inflammatory diseases, in particular, with ankylosing spondylitis and rheumatoid arthritis, Armaviscon Forte is not prescribed.
Not intended for children.
For single use only.
Requirements for the use and operation of a medical device: The product refers to single and single use products. Carrying out procedures with this medical device requires special training and special skills and is intended for use in medical institutions.
Composition of
Composition per 1 ml:
sodium hyaluronate – 20.7-25.3 mg / ml (2.3%),
sodium chloride – 8.55 mg / ml,
sodium hydrogen phosphate dihydrate – 0.33 mg / ml,
sodium dihydrogen phosphate dihydrate – 0.060 mg / ml,
water for injection – up to 1 ml.
Side effects
Mild pain, swelling, fever and redness in the injection area, increased exudate in the joint cavity may occur.
The above symptoms are transient and usually disappear after 24 hours.
When these symptoms occur, it is recommended to relieve the affected joint and apply ice.
Allergic reactions are extremely rare.
Storage conditions
Store at a temperature of + 2 ° C to + 25 ° C. Do not freeze.
Active ingredient
Sodium hyaluronate
